Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

NCT06526000 · clinicaltrials.gov ↗

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis
Clinically Isolated Syndrome
Relapsing-remitting Multiple Sclerosis
Secondary Progressive Multiple Sclerosis

Sponsor

Novartis